Evidence map›Paper›PMID 29261660›Full record

ArticlePloS one2017

Genetic analysis of Japanese primary open-angle glaucoma patients and clinical characterization of risk alleles near CDKN2B-AS1, SIX6 and GAS7.

Yukihiro Shiga, Koji M Nishiguchi, Yosuke Kawai, Kaname Kojima, Kota Sato, Kosuke Fujita, Mai Takahashi, Kazuko Omodaka, Makoto Araie, Kenji Kashiwagi and 12 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. SH-SY5Y human neuronal cells with mutations of theBiochemistry and biophysics reports · 2024
    Article
  6. Single-nucleotide polymorphisms ofExperimental biology and medicine (Maywood, N.J.) · 2023
    Article
  7. Article
  8. Article
  9. NovelMolecular vision · 2022
    Article
  10. Association ofMolecular vision · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 1 country.

Yukihiro ShigaDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Koji M NishiguchiDepartment of Advanced Ophthalmic Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Yosuke KawaiDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Kaname KojimaDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Kota SatoDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Kosuke FujitaDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Mai TakahashiDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Kazuko OmodakaDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Makoto AraieKanto Central Hospital of The Mutual Aid Association of Public School Teachers, Tokyo, Japan.
Kenji KashiwagiDepartment of Ophthalmology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Makoto AiharaDepartment of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan.
Takeshi IwataDivision of Molecular and Cellular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
Fumihiko MabuchiDepartment of Ophthalmology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Mitsuko TakamotoDepartment of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan.
Mineo OzakiOzaki Eye Hospital, Hyuga, Miyazaki, Japan.
Kazuhide KawaseGifu University Hospital, Gifu, Japan.
Nobuo FuseDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Masayuki YamamotoDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Jun YasudaDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Masao NagasakiDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Miyagi, Japan.
Toru NakazawaDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
Japan Glaucoma Society Omics Group (JGS-OG)
Tohoku University · JPThe University of Tokyo · JPUniversity of Yamanashi · JPGifu University Hospital · JPKanto Central Hospital · JPMiyata Eye Hospital · JPTokyo Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo test the genetic association between Japanese patients with primary open-angle glaucoma (POAG) and the previously reported POAG susceptibility loci and to perform genotype-phenotype analysis.

methodsGenetic associations for 27 SNPs from 16 loci previously linked to POAG were assessed using genome-wide SNP data of the primary cohort (565 Japanese POAG patients and 1,104 controls). Reproducibility of the assessment was tested in 607 POAG cases and 455 controls (second cohort) with a targeted genotyping approach. For POAG-associated variants, a genotype-phenotype correlation study (additive, dominant, recessive model) was performed using the objective clinical data derived from 598 eyes of 598 POAG patients.

resultsAmong 27 SNPs from 16 loci previously linked to POAG, genotypes for total of 20 SNPs in 13 loci were available for targeted association study. Among 8 SNPs in 3 loci that showed at least nominal association (P < 5.00E-02) in the primary cohort, a representative SNP for each loci (rs2157719 for CDKN2B-AS1, rs33912345 for SIX6, and rs9913911 for GAS7) were selected. For these SNPs the association was found significant in both the second cohort analysis and meta-analysis. The genotype-phenotype analysis revealed significant correlations between CDKN2B-AS1 (rs2157719) and decreased intraocular pressure (β = -6.89 mmHg, P = 1.70E-04; dominant model) after multiple corrections. In addition, nominal correlation was observed between CDKN2B-AS1 (rs2157719) and optic nerve head blood flow (β = -0.54 and -0.67 arbitrary units (AU), P = 2.00E-02 and 1.39E-02), between SIX6 (rs33912345) and decreased total peripapillary retinal nerve fiber layer thickness (β = -2.16 and -2.82 μm, P = 4.68E-02 and 2.40E-02, additive and recessive model, respectively) and increased optic nerve head blood flow (β = 0.44 AU, P = 2.20E-02; additive model) and between GAS7 (rs9913911) and increased cup volume (β = 0.03 mm3, P = 4.60E-02) and mean cup depth (β = 0.03 mm3, P = 4.11E-02; additive model) and decreased pattern standard deviation (β = -0.87 dB, P = 2.44E-02; dominant model).

conclusionThe association between SNPs near GAS7 and POAG was found in Japanese patients for the first time. Clinical characterization of the risk variants is an important step toward understanding the pathology of the disease and optimizing treatment of patients with POAG.

Indexed as

AllelesGenetic Predisposition to DiseaseAdultCyclin-Dependent Kinase Inhibitor p15FemaleGlaucoma, Open-AngleHomeodomain ProteinsHumansJapanMaleMiddle AgedPolymorphism, Single NucleotideTrans-ActivatorsCDKN2B protein, humanCyclin-Dependent Kinase Inhibitor p15Homeodomain ProteinsSIX6 protein, humanTrans-Activators

Identifiers

PMID29261660
PMCPMC5737967
OpenAlexW2778590979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.